Learn More
Medchemexpress LLC 4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine | 693228-63-6 | MFCD14155805 | 99.1% | 368.46 g·mol⁻¹ | C18H20N6OS | 50 MG

Supplier: Medchemexpress LLC HY1055850MG
CYC-116 is a small-molecule research compound that potently inhibits Aurora kinases A and B (Ki = 8 nM and 9 nM). It shows additional activity against VEGFR2 and other kinases and has been evaluated in preclinical and early clinical studies as an investigational anticancer agent. For research use only.
- Potent inhibition of Aurora A and B with low nanomolar Ki values.
- Activity against VEGFR2 and select tyrosine kinases.
- Demonstrated antitumor activity in preclinical models.
- Molecular formula C18H20N6OS; molecular weight 368.46 g·mol⁻¹.
- High purity suitable for research applications (≈99.1%).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.